Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Invested Capital (2016 - 2025)

Historic Invested Capital for Aytu Biopharma (AYTU) over the last 17 years, with Q4 2025 value amounting to $23.3 million.

  • Aytu Biopharma's Invested Capital fell 3307.07% to $23.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $23.3 million, marking a year-over-year decrease of 3307.07%. This contributed to the annual value of $28.0 million for FY2025, which is 691.44% down from last year.
  • Aytu Biopharma's Invested Capital amounted to $23.3 million in Q4 2025, which was down 3307.07% from $38.0 million recorded in Q3 2025.
  • Aytu Biopharma's 5-year Invested Capital high stood at $153.8 million for Q2 2021, and its period low was $23.3 million during Q4 2025.
  • Its 5-year average for Invested Capital is $63.4 million, with a median of $46.5 million in 2023.
  • Its Invested Capital has fluctuated over the past 5 years, first skyrocketed by 6158.17% in 2021, then crashed by 6145.08% in 2022.
  • Quarter analysis of 5 years shows Aytu Biopharma's Invested Capital stood at $121.8 million in 2021, then crashed by 50.06% to $60.8 million in 2022, then plummeted by 44.29% to $33.9 million in 2023, then rose by 2.65% to $34.8 million in 2024, then crashed by 33.07% to $23.3 million in 2025.
  • Its last three reported values are $23.3 million in Q4 2025, $38.0 million for Q3 2025, and $28.0 million during Q2 2025.